Sees FY23 revenue $1.14B-$1.16B, consensus $1.03B.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LNTH:
- Lantheus Blasts Up as Earnings Impress
- Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
- Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium
- Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
- Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time